Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1192-1203
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1192
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1192
Factors | B | SE | Wald χ2 | P value | HR | 95%CI |
Age (≤ 50 yr) | 1.314 | 0.430 | 9.356 | 0.002b | 3.722 | 1.603, 8.641 |
MVI | 0.828 | 0.422 | 3.846 | 0.050a | 2.288 | 1.001, 5.234 |
CNLC stage | 12.193 | 0.002b | ||||
Stage II | 0.938 | 0.496 | 3.577 | 0.059 | 2.556 | 0.967, 6.757 |
Stage III | 1.836 | 0.558 | 10.839 | 0.001b | 6.272 | 2.102, 18.712 |
Irregular shape | 1.292 | 0.380 | 11.550 | 0.001b | 3.638 | 1.728, 7.663 |
Large vessel invasion | 1.736 | 0.557 | 9.728 | 0.002b | 5.675 | 1.906, 16.896 |
- Citation: Chen JP, Yang RH, Zhang TH, Liao LA, Guan YT, Dai HY. Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection. World J Gastrointest Oncol 2024; 16(4): 1192-1203
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1192.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1192